loadpatents
Patent applications and USPTO patent grants for Lindstrom; Andrew K..The latest application filed is for "therapeutic piperazines".
Patent | Date |
---|---|
Therapeutic piperazines Grant 9,624,200 - Kaplan , et al. April 18, 2 | 2017-04-18 |
Therapeutic Piperazines App 20150087645 - Kaplan; Alan P. ;   et al. | 2015-03-26 |
Therapeutic piperazines Grant 8,927,546 - Kaplan , et al. January 6, 2 | 2015-01-06 |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR Grant 7,915,253 - Noble , et al. March 29, 2 | 2011-03-29 |
Therapeutic Piperazines App 20110065691 - Kaplan; Alan P. ;   et al. | 2011-03-17 |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR Grant 7,834,004 - Noble , et al. November 16, 2 | 2010-11-16 |
Sulfonyl-substituted Bicyclic Compounds As Modulators Of Ppar App 20090264417 - Noble; Stewart A. ;   et al. | 2009-10-22 |
Sulfonyl-substituted Bicyclic Compounds As Modulators Of Ppar App 20090227599 - Noble; Stewart A. ;   et al. | 2009-09-10 |
Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors App 20090143396 - Malecha; James W. ;   et al. | 2009-06-04 |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR Grant 7,517,884 - Malecha , et al. April 14, 2 | 2009-04-14 |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR Grant 7,494,999 - Noble , et al. February 24, 2 | 2009-02-24 |
Sulfonyl-substituted Bicyclic Compounds As Modulators Of Ppar App 20090029971 - Noble; Stewart A. ;   et al. | 2009-01-29 |
Novel Compounds as Modulators of Ppar App 20080287477 - Malecha; James W. ;   et al. | 2008-11-20 |
Quinolones Useful As Inducible Nitric Oxide Synthase Inhibitors App 20080139558 - Smith; Nicholas D. ;   et al. | 2008-06-12 |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR App 20060205736 - Noble; Stewart A. ;   et al. | 2006-09-14 |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR App 20060167012 - Noble; Stewart A. ;   et al. | 2006-07-27 |
Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders App 20050234046 - Zhao, Cunxiang ;   et al. | 2005-10-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.